Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rh-Hr Blood-Group System | 1 | 2020 | 55 | 0.85 | Why? |
| Tick-Borne Diseases | 1 | 2020 | 68 | 0.76 | Why? |
| Anemia, Hemolytic, Congenital | 1 | 2017 | 4 | 0.74 | Why? |
| Substance Abuse Detection | 1 | 2020 | 192 | 0.73 | Why? |
| Hydrops Fetalis | 1 | 2017 | 33 | 0.71 | Why? |
| Coxiella burnetii | 1 | 2018 | 120 | 0.69 | Why? |
| Disease Notification | 2 | 2020 | 639 | 0.64 | Why? |
| Q Fever | 1 | 2018 | 130 | 0.64 | Why? |
| Vitamin D Deficiency | 2 | 2020 | 1782 | 0.58 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.54 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.54 | Why? |
| Delayed Diagnosis | 2 | 2021 | 1529 | 0.52 | Why? |
| Vitamin D | 2 | 2020 | 2904 | 0.51 | Why? |
| Hepatitis C | 2 | 2021 | 1514 | 0.47 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.45 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.40 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.40 | Why? |
| African Americans | 2 | 2020 | 3363 | 0.36 | Why? |
| Opioid-Related Disorders | 1 | 2020 | 1185 | 0.36 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.31 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.29 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.27 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.27 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.27 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.26 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.24 | Why? |
| Neoplasms | 2 | 2021 | 17251 | 0.23 | Why? |
| Chlamydia | 1 | 2021 | 47 | 0.22 | Why? |
| Colorado Tick Fever | 1 | 2020 | 3 | 0.21 | Why? |
| Rocky Mountain Spotted Fever | 1 | 2020 | 6 | 0.21 | Why? |
| Occupational Health | 1 | 2017 | 3965 | 0.21 | Why? |
| Ehrlichiosis | 1 | 2020 | 18 | 0.21 | Why? |
| Relapsing Fever | 1 | 2020 | 14 | 0.21 | Why? |
| Anaplasmosis | 1 | 2020 | 21 | 0.21 | Why? |
| Babesiosis | 1 | 2020 | 22 | 0.21 | Why? |
| Tularemia | 1 | 2020 | 25 | 0.20 | Why? |
| Blood Grouping and Crossmatching | 1 | 2020 | 125 | 0.20 | Why? |
| United States | 9 | 2021 | 46150 | 0.20 | Why? |
| Analgesics, Opioid | 2 | 2020 | 1070 | 0.19 | Why? |
| Fentanyl | 1 | 2020 | 142 | 0.19 | Why? |
| Aerobiosis | 1 | 2017 | 12 | 0.18 | Why? |
| Chlamydia Infections | 1 | 2021 | 248 | 0.18 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.17 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.17 | Why? |
| Prescription Drug Misuse | 1 | 2017 | 54 | 0.17 | Why? |
| Gonorrhea | 1 | 2021 | 315 | 0.16 | Why? |
| Nucleic Acid Amplification Techniques | 2 | 2020 | 3388 | 0.16 | Why? |
| Benzodiazepines | 1 | 2017 | 163 | 0.15 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.15 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.15 | Why? |
| Resistance Training | 1 | 2017 | 273 | 0.14 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.14 | Why? |
| Hepacivirus | 2 | 2021 | 1509 | 0.14 | Why? |
| Sexually Transmitted Diseases | 1 | 2021 | 694 | 0.12 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Female | 15 | 2021 | 380317 | 0.12 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.12 | Why? |
| Glycated Hemoglobin A | 1 | 2020 | 1316 | 0.12 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.11 | Why? |
| Adult | 11 | 2021 | 244371 | 0.10 | Why? |
| Aged | 8 | 2021 | 215776 | 0.10 | Why? |
| Humans | 19 | 2021 | 930598 | 0.10 | Why? |
| Male | 12 | 2021 | 367725 | 0.10 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.09 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.09 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.09 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.09 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.09 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.09 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.09 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.09 | Why? |
| Seasons | 1 | 2020 | 4071 | 0.09 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.08 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.08 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.08 | Why? |
| Substance-Related Disorders | 1 | 2020 | 2038 | 0.08 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2020 | 1969 | 0.07 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.07 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.07 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.05 | Why? |
| Child | 2 | 2020 | 70012 | 0.05 | Why? |
| Infant | 2 | 2020 | 30274 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 2 | 2020 | 11559 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Kaufman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(108)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(57)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_